Thaïs Lestra

Ms. Thaïs Lestra


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AGAmandine Géraudie
Amandine Géraudie
MRMaximilien Riche
Maximilien Riche
TLThaïs Lestra
Thaïs Lestra
ATAlexandre Trotier
Alexandre Trotier
LDLéo Dupuis
Léo Dupuis
BDBenoît Delatour
Benoît Delatour
Alzheimer’s disease (AD) is the leading cause of dementia. No treatments have led to clinically meaningful impacts. A major obstacle for peripherally administered therapeutics targeting the central nervous system is related to the blood–brain barrier (BBB). Ultrasounds associated with microbubbles have been shown to transiently and safely open the BBB. In AD mouse models, the sole BBB opening with no adjunct drugs may be sufficient to reduce lesions and mitigate cognitive decline. However, these therapeutic effects are for now mainly assessed in preclinical mouse models of amyloidosis and remain less documented in tau lesions. The aim of the present study was therefore to evaluate the effects of repeated BBB opening using low-intensity pulsed ultrasounds (LIPU) in tau transgenic P301S mice with two main readouts: tau-positive lesions and microglial cells. Our results show that LIPU-induced BBB opening does not decrease tau pathology and may even potentiate the accumulation of pathological tau in selected brain regions. In addition, LIPU-BBB opening in P301S mice strongly reduced microglia densities in brain parenchyma, suggesting an anti-inflammatory action. These results provide a baseline for future studies using LIPU-BBB opening, such as adjunct drug therapies, in animal models and in AD patients.

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
AGAmandine Géraudie
Amandine Géraudie
MRMaximilien Riche
Maximilien Riche
TLThaïs Lestra
Thaïs Lestra
ACAlexandre Carpentier
Alexandre Carpentier
BDBenoît Delatour
Benoît Delatour
Background: Alzheimer’s disease is the most frequent cause of dementia. To date, almost no disease‐modifying therapeutics have proven clinical efficacy. Most of these therapeutics have targeted amyloidosis whereas tau pathology is better correlated to cognitive decline. Moreover, drugs have difficulty crossing the blood‐brain barrier (BBB) which drastically restricts their penetration into the brain parenchyma. It has been previously shown that the BBB can be safely, transiently and repeatedly opened using low‐intensity pulsed ultrasound along with microbubbles (LIPU‐MB, sonication). BBB opening with LIPU‐MB alone provides beneficial effects on amyloid burden, increase neurogenesis and modulate neuroinflammation. Our study aims at evaluating the effect of LIPU‐MB BBB opening in P301S mice model of tauopathy on tau pathology. Its secondary aims are to evaluate the effects of LIPU‐MB BBB opening on neuroinflammation, synapse density and neurogenesis.Methods: Five sessions (one per week) of LIPU‐MB were administered to wild‐type and P301S mice. Mice were sacrificed one week after the last session. Immunostaining of phosphorylated tau (AT8), microglia (Iba‐1), synapse (synaptophysin) and neurogenesis (doublecortin) were compared between the sonicated and non‐sonicated groups.Results: There was a global trend for an increase of phosphorylated tau, significant in the piriform cortex, in sonicated P301S male mice (p<.05). Interestingly, microglial densities were decreased in all brain areas in these mice (p<.0001) whereas they were increased in wild‐type mice. Tau pathology and microglial density differences between sonicated and non‐sonicated animals did not appear anymore in P301S female mice. Synapse density and neurogenesis in the hippocampus did not appear to be affected by sonication in P301S mice.Conclusion: Our results show that LIPU‐MB BBB opening decreases microglial cells loads in P301S male mice and concomitantly may impact tangles pathology. They also underline that the effects of transient BBB opening may be both sex‐ and genotype‐dependent. These results could have therapeutical impact for Alzheimer’s disease but need to be confirmed in larger cohorts of mice.